GINO SANTINI
CIK 1276038 · Sr.VP, Corp. Strategy & BD · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$122.83M
Companies
9
Total Filings
72
Lifetime Open-Market Net
-$1.30M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COLL | Director | 112,483 | $34.64 | $3.90M | -$201.0K | 10 | 2026-06-10 |
| CMPS | Director | — | $12.08 | — | $0 | 3 | 2026-05-29 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Director | 0 | $116.30 | $0 | -$1.10M | 21 | 2023-10-06 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 31,756 | $19.00 | $603.4K | $0 | 9 | 2023-05-25 |
| Allena Pharmaceuticals, Inc. (ALNA) Delisted | Director | — | $0.07 | — | $0 | 4 | 2021-06-04 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Director | 0 | — | — | $0 | 10 | 2020-11-17 |
| ESPR | Director | 30,148 | $3.15 | $95.0K | $0 | 4 | 2019-04-29 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | Director | — | — | — | $0 | 4 | 2016-10-25 |
| LLY | Sr.VP, Corp. Strategy & BD | 104,886 | $1133.00 | $118.84M | $0 | 6 | 2009-02-03 |
Recent Filings · Page 3 of 8
72 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-01 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +7,029 | $0 | EDGAR |
| 2021-05-24 | COLL | Grant (A) | +9,941 | $0 | EDGAR |
| 2021-04-30 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +6,741 | -$412.3K | EDGAR |
| 2021-03-03 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Sell (S) | −12,000 | -$1.10M | EDGAR |
| 2020-11-18 | Allena Pharmaceuticals, Inc. (ALNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-11-17 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Disp (D) | −41,473 | $0 | EDGAR |
| 2020-08-04 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Exer (M) | +35,795 | $103.3K | EDGAR |
| 2020-06-04 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Grant (A) | +10,269 | $0 | EDGAR |
| 2020-06-01 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +1,595 | $0 | EDGAR |
| 2020-05-22 | COLL | Grant (A) | +4,047 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.